Navigation Links
Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results

IRVINE, Calif., May 10, 2011 /PRNewswire/ -- PRO-DEX, INC. (Nasdaq: PDEX) today announced financial results for its fiscal third quarter and nine months ended March 31, 2011.

Sales for the quarter ended March 31, 2011 were $7.6 million, 24% higher than sales of $6.2 million for the corresponding quarter in 2010.  For the nine months ended March 31, 2011, sales were $19.6 million, 12% higher than sales of $17.5 million for the corresponding period in 2010.  These results for both the quarter and the nine-month periods were due primarily to increases in sales of the Company's medical device products to its two largest customers, with the nine-month period also benefitting from growth in sales of the Company's motion control products.  

Operating income was $1.1 million for the quarter, a 177% improvement from $409,000 for the corresponding 2010 period.  For the nine months ended March 31, 2011, operating income improved 171% to $2.1 million from $778,000 for the corresponding nine-month period in 2010.

Net income for the 2011 quarter was $868,000, or $0.26 per fully-diluted share, which represents a 399% increase from net income of $174,000, or $0.05 per fully-diluted share, for the corresponding 2010 quarter.  For the nine months ended March 31, 2011, net income was $1.6 million, an increase of 72% from net income of $937,000 for the corresponding period in 2010.  

Gross profit for the quarter ended March 31, 2011 increased to $2.9 million, a 38% gross profit margin, compared to gross profit of $2.3 million, a 37% gross profit margin, for the year-ago period.  For the nine months ended March 31, 2011, gross profit was $7.5 million, a 38% gross profit margin, compared to gross profit and margin of $6.2 million and 35%, respectively, for the corresponding nine-month period in 2010.  The increase in gross profit as a percentage of sales during both periods was due to a change in mix toward sales of medical device and motion control products at relatively higher margins, and to cost reductions.Mark Murphy, the Company's President and Chief Executive Officer, commented, "We are very pleased with the results through the first nine months of fiscal 2011.   Sales and profitability for the third quarter continue to be strong, however looking forward, we remain committed to taking the necessary steps to diversify our customer base as these results may not represent the future buying pattern of our largest customer."

The Company also announced that Mr. Paul Rudzinski has joined the Company as Vice President of Sales.  Mr. Rudzinski brings 29 years of sales and sales leadership experience, most of which has been in the medical device space.  Mr. Murphy commented "We are delighted to have Paul join us and believe that the combination of his experience, leadership, and industry relationships will connect the substantial capabilities of Pro-Dex with the right customers." 

Commenting on the Company's cash generation in the third quarter, Mr. Murphy concluded, "During this nine-month period of increased sales which was accompanied by higher levels of accounts receivable and inventory, Pro-Dex nonetheless generated $1.8 million of cash from operations."

Teleconference Information:Investors and analysts are invited to listen to a broadcast review of the Company's fiscal 2011 third quarter financial results today at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time) that may be accessed by visiting the Company's website at  The conference call may also be accessed at Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S.

For those who cannot access the live broadcast, a replay will be available from two hours after the completion of the call until midnight (Eastern Time) on May 21, 2011 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S., and then entering account number 286 and conference I.D. number 372315.  An online archive of the broadcast will be available on the Company's website for a period of 365 days.

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.  For more information, visit the Company's website at

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.(tables follow)PRO-DEX, INC. and SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(unaudited)March 31, 2011

June 30, 2010ASSETSCurrent assets:Cash and cash equivalents

$   3,778,000

$   3,794,000Accounts receivable, net of allowance for doubtful accountsof $8,000 at March 31, 2011 and $25,000 at June 30, 2010


2,682,000Other current receivables




3,228,000Prepaid expenses


174,000Deferred income taxes


209,000Total current assets


10,109,000Property, plant, equipment and leasehold improvements, net


4,092,000Other assets


78,000Total assets

$ 14,596,000

$ 14,279,000LIABILITIES AND SHAREHOLDERS' EQUITYCurrent liabilities:Accounts payable

$   1,477,000

$   1,279,000Accrued expenses


1,947,000Income taxes payable


79,000Current portion of bank term loan


400,000Current portion of real estate loan


35,000Total current liabilities


3,740,000Long-term liabilities:Bank term loan


967,000Real estate loan


1,493,000Deferred income taxes


209,000Deferred rent


255,000Total long-term liabilities


2,924,000Total liabilities


6,664,000Commitments and contingencies Shareholders' equity:Common shares; no par value; 50,000,000 shares authorized;3,272,350 shares issued and outstanding at March 31, 20113,251,850 shares issued and outstanding at June 30, 2010


16,675,000Accumulated deficit


(9,060,000)Total shareholders’ equity


7,615,000Total liabilities and shareholders’ equity

$ 14,596,000

$ 14,279,000PRO-DEX, INC. and SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF INCOME(unaudited)For The Three Months Ended March 31,2011

2010Net sales


,161,000Cost of sales


3,869,000Gross profit


2,292,000Operating expenses:Selling expenses


383,000General and administrative expenses


886,000Research and development costs


614,000Total operating expenses


1,883,000Income from operations


409,000Other income (expense):Royalty income


40,000Interest expense


(50,000)Total other income (expense)


(10,000)Income before provision for income taxes


399,000Provision for income taxes


225,000Net income


74,000Net income per share:Basic




.05Weighted average shares outstanding - basic


3,234,538Weighted average shares outstanding - diluted


3,240,564PRO-DEX, INC. and SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF INCOME(unaudited)For the Nine Months Ended March 31,2011

2010Net sales

$ 19,612,000

$ 17,490,000Cost of sales


11,324,000Gross profit


6,166,000Operating expenses: Selling expense


1,025,000General and administrative expenses


2,412,000Impairment of intangible asset


140,000Research and development costs


1,811,000Total operating expenses


5,388,000Income from operations


778,000Other income (expense): Royalty income


44,000Interest expense


(154,000)Total other income (expense)


(110,000)Income before provision (benefit) for income taxes


668,000Provision (benefit) for income taxes


(269,000)Net income

$   1,612,000

937,000Net income per share:Basic




.29Weighted average shares outstanding - basic


3,226,716Weighted average shares outstanding - diluted



2010Cash flows from operating activities: Net income

$   1,612,000

937,000Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization


546,000Impairment of intangible asset


140,000(Decrease) in allowance for doubtful accounts


(1,000)Stock based compensation


96,000Increase in deferred tax allowance


118,000Changes in:(Increase) in accounts receivable and other current receivables


(245,000)(Increase) decrease in inventories


509,000(Increase) in prepaid expenses


(115,000)Decrease in other assets


-Increase in accounts payable and accrued expenses


712,000Increase (decrease) in income taxes payable


(36,000)Net cash provided by operating activities


2,661,000Cash flows from investing activities: Purchases of equipment and leasehold improvements


(109,000)Net cash (used in) investing activities


(109,000)Cash flows from financing activities:Principal payments on bank term loan


(300,000)Net proceeds from bank term loan refinancing


-Principal payments on real estate loan


(24,000)Proceeds from exercise of stock options


-Net cash (used in) financing activities


(324,000)Net (decrease) increase in cash and cash equivalents


2,228,000Cash and cash equivalents, beginning of period


1,124,000Cash and cash equivalents, end of period

$   3,778,000

$   3,352,000Supplemental InformationCash payments for interest


57,000Cash payments for income taxes



SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2011 Third Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Announces Fiscal Second Quarter and Six Month Results
3. Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer
4. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
6. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
7. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
8. Ethicon, Inc. Announces Availability of ETHICON SECURESTRAP™ 5mm Absorbable Strap Fixation Device
9. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
10. Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™
11. Insmed Announces First Quarter 2011 Financial Results
Post Your Comments:
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
(Date:11/25/2015)... 25, 2015  Henry Schein, Inc., the world,s largest ... dental, medical and animal health practitioners, will unveil at ... Henry Schein ConnectDental® Pavilion , which brings together for ... solutions designed to help any practice or laboratory enter ... for a schedule of experts appearing at the Pavilion. ...
Breaking Medicine Technology:
(Date:11/26/2015)... Las Vegas, NV (PRWEB) , ... November 26, 2015 , ... ... holiday shopping strategy. Many customers choose to buy during the Black Friday and ... holiday gifts. Shoppers don’t need to search the Internet high and low to find ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied ... the need to integrate dose form selection in early phase drug development. The ... organization supporting and bringing together the UK’s emerging life sciences companies, corporate partners, ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/26/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the world-class Asterisk based ... efficiency and reliability. , The new Q-Suite 6 platform is based on the latest ... itself into a specific piece of software for many key components of the suite. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the perfect dish and pleasing the palates of attendees is of the utmost ... dish to a seasonal get-together, give these recipes a try this holiday season. ...
Breaking Medicine News(10 mins):